Reid Bissonette
Overview
Explore the profile of Reid Bissonette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Medina D, Kittrell F, Hill J, Zhang Y, Hilsenbeck S, Bissonette R, et al.
Cancer Prev Res (Phila)
. 2009 Jan;
2(2):168-74.
PMID: 19174577
The chemopreventive effects of three agents, rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib, were tested on mammary tumor development arising in p53-null mammary epithelium. The rexinoid bexarotene was the...
2.
Cohen K, Liu T, Bissonette R, Puri R, Frankel A
Curr Pharm Biotechnol
. 2003 Feb;
4(1):39-49.
PMID: 12570681
Primary brain tumors including anaplastic astrocytomas and glioblastoma multiforme are difficult to treat because of their locally invasive nature and chemoradioresistance. Novel therapies are needed. One class of therapeutics is...
3.
Wu K, Zhang Y, Xu X, Hill J, Celestino J, Kim H, et al.
Cancer Res
. 2002 Nov;
62(22):6376-80.
PMID: 12438218
Despite the effectiveness of the selective estrogen receptor (ER) modulators in preventing ER-positive breast cancer, chemopreventive agents still need to be developed for the prevention of ER-negative breast cancers. The...